99 related articles for article (PubMed ID: 6966604)
1. Hybridization between T and B lymphoma cell lines.
Taussig MJ; Holliman A; Wright LJ
Immunology; 1980 Jan; 39(1):57-60. PubMed ID: 6966604
[TBL] [Abstract][Full Text] [Related]
2. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
[TBL] [Abstract][Full Text] [Related]
3. T lymphocyte tissue culture lines produced by cell hybridization.
Hämmerling GJ
Eur J Immunol; 1977 Oct; 7(10):743-6. PubMed ID: 304002
[TBL] [Abstract][Full Text] [Related]
4. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers.
Zeuthen J; Klein G; Ber R; Masucci G; Bisballe S; Povey S; Terasaki P; Ralph P
J Natl Cancer Inst; 1982 Feb; 68(2):179-95. PubMed ID: 6278187
[TBL] [Abstract][Full Text] [Related]
5. Derivation of hybrids between a thymoma line and spleen cells activated in a mixed leukocyte reaction.
Köhler G; Lefkovits I; Elliott B; Coutinho A
Eur J Immunol; 1977 Nov; 7(11):758-61. PubMed ID: 563329
[TBL] [Abstract][Full Text] [Related]
6. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
7. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
[TBL] [Abstract][Full Text] [Related]
8. T-cell hybrids. II. BH2 line-derivation by fusion between two (BW5147 X EL-4R) thymoma lines.
Bubeník J; Perlmann P; Jónsdóttir I; Kypĕnová H; Bubeníková D; Indrová M; Loudová M
Neoplasma; 1982; 29(1):3-7. PubMed ID: 6978467
[No Abstract] [Full Text] [Related]
9. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
10. Induction of differentiation in a B lymphoma X B lymphocyte hybrid line. II. Intraclonal heterogeneity in growth, secretion of IgM, and cytokine production in response to lipopolysaccharide.
Little J; Alling DW; Asofsky R
J Immunol; 1993 Mar; 150(6):2129-38. PubMed ID: 8450206
[TBL] [Abstract][Full Text] [Related]
11. Mixed haplotype A beta Z/A alpha d class II molecule in (NZB x NZW)F1 mice detected by T cell clones.
Gotoh Y; Takashima H; Noguchi K; Nishimura H; Tokushima M; Shirai T; Kimoto M
J Immunol; 1993 Jun; 150(11):4777-87. PubMed ID: 8496588
[TBL] [Abstract][Full Text] [Related]
12. T-cell hybrids. III. Low tumorigenicity of hybrid cells derived from fusion of high tumorigenic (BW5147 X EL-4R) cell lines.
Bubeník J; Símová J
Folia Biol (Praha); 1982; 28(4):274-9. PubMed ID: 6982835
[TBL] [Abstract][Full Text] [Related]
13. Two dominant host resistance genes to pre-B lymphoma in wild-derived inbred mouse strain MSM/Ms.
Pataer A; Kamoto T; Lu LM; Yamada Y; Hiai H
Cancer Res; 1996 Aug; 56(16):3716-20. PubMed ID: 8706013
[TBL] [Abstract][Full Text] [Related]
14. Peripheral CD4+ T cell maturation recognized by increased expression of Thy-1/CD90 bearing the 6C10 carbohydrate epitope.
Gui M; Wiest DL; Li J; Kappes D; Hardy RR; Hayakawa K
J Immunol; 1999 Nov; 163(9):4796-804. PubMed ID: 10528179
[TBL] [Abstract][Full Text] [Related]
15. B-1a cell origin of the murine B lymphoma line BCL1 characterized by surface markers and bacterial reactivity of its surface IgM.
Koganei S; Ito M; Yamamoto K; Matsumoto N
Immunol Lett; 2005 May; 98(2):232-44. PubMed ID: 15860223
[TBL] [Abstract][Full Text] [Related]
16. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.
Burton RC; Warner NL
J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529
[TBL] [Abstract][Full Text] [Related]
17. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes.
Brooks DA; Beckman IG; Bradley J; McNamara PJ; Thomas ME; Zola H
J Immunol; 1981 Apr; 126(4):1373-7. PubMed ID: 6970772
[TBL] [Abstract][Full Text] [Related]
18. Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.
Murrell AM; Green AR
Oncogene; 1995 Feb; 10(4):631-9. PubMed ID: 7862440
[TBL] [Abstract][Full Text] [Related]
19. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
King CA; Wills MR; Hamblin TJ; Stevenson FK
Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage.
Abramson CS; Kersey JH; LeBien TW
J Immunol; 1981 Jan; 126(1):83-8. PubMed ID: 6969748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
